Charles Schwab’s Imperva, Inc. IMPV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-186,175
Closed -$10.4M 3239
2018
Q4
$10.4M Buy
186,175
+1,638
+0.9% +$89K 0.01% 1436
2018
Q3
$8.57M Buy
184,537
+11,549
+7% +$559K 0.01% 1740
2018
Q2
$8.35M Buy
172,988
+11,266
+7% +$539K 0.01% 1714
2018
Q1
$7M Buy
161,722
+5,665
+4% +$254K 0.01% 1746
2017
Q4
$6.2M Buy
156,057
+17,453
+13% +$727K ﹤0.01% 1802
2017
Q3
$6.02M Buy
138,604
+6,842
+5% +$312K 0.01% 1780
2017
Q2
$6.3M Buy
131,762
+12,287
+10% +$573K 0.01% 1673
2017
Q1
$4.91M Buy
119,475
+6,309
+6% +$263K ﹤0.01% 1767
2016
Q4
$4.35M Buy
113,166
+5,785
+5% +$235K ﹤0.01% 1820
2016
Q3
$5.77M Buy
107,381
+9,920
+10% +$460K 0.01% 1546
2016
Q2
$4.19M Buy
97,461
+5,914
+6% +$248K 0.01% 1675
2016
Q1
$4.62M Buy
91,547
+2,033
+2% +$97.8K 0.01% 1559
2015
Q4
$5.67M Buy
89,514
+2,542
+3% +$173K 0.01% 1435
2015
Q3
$5.7M Buy
86,972
+1,758
+2% +$117K 0.01% 1387
2015
Q2
$5.77M Buy
85,214
+8,481
+11% +$468K 0.01% 1454
2015
Q1
$3.28M Buy
76,733
+8,703
+13% +$387K ﹤0.01% 1777
2014
Q4
$3.36M Buy
68,030
+2,315
+4% +$92.7K 0.01% 1710
2014
Q3
$1.89M Buy
65,715
+6,144
+10% +$167K ﹤0.01% 1996
2014
Q2
$1.56M Buy
59,571
+3,329
+6% +$86K ﹤0.01% 2109
2014
Q1
$3.13M Buy
56,242
+4,855
+9% +$279K 0.01% 1679
2013
Q4
$2.47M Buy
51,387
+1,751
+4% +$73.7K ﹤0.01% 1777
2013
Q3
$2.04M Buy
49,636
+9,309
+23% +$443K ﹤0.01% 1829
2013
Q2
$1.8M Buy
+40,327
New +$1.58M ﹤0.01% 1829

Charles Schwab's IMPV Position: Q1 2019 in Review

Charles Schwab sold out of Imperva, Inc. (IMPV) in Q1 2019, closing a stake of 186,175 shares — an estimated $10.4M sold.

Charles Schwab first reported a position in IMPV in Q2 2013 and held it in 23 quarters. The position peaked at $10.4M in Q4 2018. 0 funds tracked by Wall St. Rank hold IMPV as of Q1 2019.

  • Charles Schwab reported no remaining Imperva, Inc. position as of Q1 2019 after selling out during the quarter.
  • Charles Schwab sold 186,175 Imperva, Inc. shares in Q1 2019, an estimated $10.4M.
  • Charles Schwab first reported a position in Imperva, Inc. in Q2 2013 and held it in 23 quarters.
  • Charles Schwab's Imperva, Inc. position peaked at $10.4M in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Imperva, Inc. as of Q1 2019.

Based on Charles Schwab's 13F filing for Q1 2019, filed 14 May 2019.